How Coronavirus Took Hold in North America and Europe

Sep 10, 2020

A new study out today combines evolutionary genomics from coronavirus samples with computer-simulated epidemics and detailed travel records to reconstruct the spread of coronavirus across the world in unprecedented detail.

Published in the journal Science, the results suggest an extended period of missed opportunity when intensive testing and contact tracing might have prevented SARS-CoV-2 from becoming established in North America and Europe.

Coronavirus (Image: Pixabay)The paper also challenges suggestions that linked the earliest known cases of COVID-19 on each continent in January to outbreaks detected weeks later, and provides valuable insights that could inform public health response and help with anticipating and preventing future outbreaks of COVID-19 and other zoonotic diseases.

“Our aspiration was to develop and apply powerful new technology to conduct a definitive analysis of how the pandemic unfolded in space and time, across the globe,” said University of Arizona researcher Michael Worobey, PhD, who led an interdisciplinary team of scientists from 13 research institutions in the U.S., Belgium, Canada and the U.K. “Before, there were lots of possibilities floating around in a mishmash of science, social media and an unprecedented number of preprint publications still awaiting peer review.”

The team based their analysis on results from viral genome sequencing efforts, which began immediately after the virus was identified and quickly grew into a worldwide effort, unprecedented in scale and pace, that has yielded tens of thousands of genome sequences, publicly available in databases.

Contrary to widespread narratives, the first documented arrivals of infected individuals traveling from China to the U.S. and Europe did not snowball into continental outbreaks, the researchers found.

Instead, swift and decisive measures aimed at tracing and containing those initial incursions of the virus were successful and should serve as model responses directing future actions and policies by governments and public health agencies, the study’s authors conclude.

How the Virus Arrived in the U.S. and Europe

A Chinese national flying into Seattle from Wuhan, China on Jan. 15 became the first patient in the U.S. shown to be infected with the novel coronavirus and the first to have a SARS-CoV-2 genome sequenced. This patient was designated “WA1.” It was not until six weeks later that several additional cases were detected in Washington state.

“And while all that time goes past, everyone is in the dark and wondering, ‘What’s happening?’’ said Dr. Worobey, head of the UArizona Department of Ecology and Evolutionary Biology and a member of university’s BIO5 Institute. “We hope we’re OK, we hope there are no other cases, and then it becomes clear, from a remarkable community viral sampling program in Seattle, that there are more cases in Washington and they are genetically very similar to WA1’s virus.”

This schematic map shows early and apparently Dr. Worobey and his collaborators tested the prevailing hypothesis suggesting that patient WA1 had established a transmission cluster that went undetected for six weeks. Although the genomes sampled in February and March share similarities with WA1, they are different enough that the idea of WA1 establishing the ensuing outbreak is very unlikely, they determined. The researchers’ findings indicate that the jump from China to the U.S. likely occurred on or around Feb. 1 instead.

The results also put to rest speculation that the Washington outbreak – the earliest substantial transmission cluster in the U.S. – may have been initiated indirectly by dispersal of the virus from China to British Columbia, Canada, just north of Washington State, and then spread from Canada to the U.S.

Multiple SARS-CoV-2 genomes published by the British Columbia Center for Disease Control appeared to be ancestral to the viral variants sampled in Washington state, strongly suggesting a Canadian origin of the U.S. epidemic. However, the present study revealed sequencing errors in those genomes, thus ruling out that scenario. 

Instead, the new study implicates a direct-from-China source of the U.S. outbreak, right around the time the U.S. administration implemented a travel ban for travelers from China in early February. The nationality of the “index case” of the U.S. outbreak cannot be known for certain because tens of thousands of U.S. citizens and visa holders traveled from China to the U.S. even after the ban took effect.

A similar scenario marks the first known introduction of coronavirus into Europe. On Jan. 20, an employee of an automotive supply company in Bavaria, Germany, flew in for a business meeting from Shanghai, China, unknowingly carrying the virus and ultimately leading to infection of 16 co-workers. In that case, too, an impressive response of rapid testing and isolation prevented the outbreak from spreading any further, the study concludes. Contrary to speculation, this German outbreak was not the source of the outbreak in Northern Italy that eventually spread widely across Europe and eventually to New York City and the rest of the U.S.

The authors also show that this China-to-Italy-to-U.S. dispersal route ignited transmission clusters on the East Coast slightly later in February than the China-to-U.S. movement of the virus that established the Washington state outbreak. The Washington transmission cluster also predated small clusters of community transmission in February in California, making it the earliest anywhere in North America.

Early Containment Works

The authors say intensive interventions, involving testing, contact tracing, isolation measures and a high degree of compliance of infected individuals – who reported their symptoms to health authorities and self-isolated in a timely manner – helped Germany and the Seattle area contain those outbreaks in January.

“We believe that those measures resulted in a situation where the first sparks could successfully be stamped out, preventing further spread into the community,” Dr. Worobey said. “What this tells us is that the measures taken in those cases are highly effective and should serve as a blueprint for future responses to emerging diseases that have the potential to escalate into worldwide pandemics.”

Click to view study.

To reconstruct the pandemic’s unfolding, the scientists ran computer programs that carefully simulated the epidemiology and evolution of the virus – in other words, how SARS-CoV-2 spread and mutated over time.

“This allowed us to rerun the tape of how the epidemic unfolded, over and over again, and then check the scenarios that emerge in the simulations against the patterns we see in reality,” Dr. Worobey said.

“In the Washington case, we can ask, ‘What if that patient WA1 who arrived in the U.S. on Jan. 15, really did start that outbreak?’ Well, if he did, and you re-run that epidemic over and over and over and then sample infected patients from that epidemic and evolve the virus in that way, do you get a pattern that looks like what we see in reality? And the answer was no,” he said.

“If you seed that early Italian outbreak with the one in Germany, do you see the pattern that you get in the evolutionary data? And the answer, again, is no,” he said.

“By re-running the introduction of SARS-CoV-2 into the U.S. and Europe through simulations, we showed that it was very unlikely that the first documented viral introductions into these locales led to productive transmission clusters,” said study co-author Joel Wertheim of the University of California, San Diego. “Molecular epidemiological analyses are incredibly powerful for revealing transmissions patterns of SARS-CoV-2.”

Other methods were then combined with the data from the virtual epidemics, yielding exceptionally detailed and quantitative results.

“Fundamental to this work stands our new tool combining detailed travel history information and phylogenetics, which produces a sort of ‘family tree’ of how the different genomes of virus sampled from infected individuals are related to each other,” said co-author Marc Suchard, PhD, of the University of California, Los Angeles.

“Our research shows that when you do early intervention and detection well, it can have a massive impact, both on preventing pandemics and controlling them once they progress,” Dr. Worobey said. “While the epidemic eventually slipped through, there were early victories that show us the way forward: Comprehensive testing and case identification are powerful weapons.”

Funding sources for the study include the David and Lucile Packard Foundation, the National Institutes of Health, the European Research Council, the Wellcome Trust and the Canadian Institutes of Health Research Coronavirus Rapid Response Programme. For a complete list of authors and funding agencies, see the research paper, “The emergence of SARS-CoV-2 in Europe and North America,” in Science. Among co-authors from UArizona was Brendan Larsen, a graduate student who works in Dr. Worobey’s lab.

The UArizona Health Sciences COVID-19 Research webpage can be found here.

For the latest on the University of Arizona response to the novel coronavirus, visit the university's COVID-19 webpage.

For UANews coverage of COVID-19, visit https://news.arizona.edu/news/covid19.

# # #

A version of this article appeared originally on the UANews website.

NOTE: Images available upon request.

About the University of Arizona Health Sciences
The University of Arizona Health Sciences is the statewide leader in biomedical research and health professions training. UArizona Health Sciences includes the Colleges of Medicine (Tucson and Phoenix), Nursing, Pharmacy, and the Mel and Enid Zuckerman College of Public Health, with main campus locations in Tucson and the Phoenix Biomedical Campus in downtown Phoenix. From these vantage points, Health Sciences reaches across the state of Arizona, the greater Southwest and around the world to provide next-generation education, research and outreach. A major economic engine, Health Sciences employs nearly 5,000 people, has approximately 4,000 students and 900 faculty members, and garners $200 million in research grants and contracts annually. For more information: uahs.arizona.edu (Follow us: Facebook | Twitter | YouTube | LinkedIn | Instagram).

About the University of Arizona
The University of Arizona, a land-grant university with two independently accredited medical schools, is one of the nation's top public universities, according to U.S. News & World Report. Established in 1885, the university is widely recognized as a student-centric university and has been designated as a Hispanic Serving Institution by the U.S. Department of Education. The university ranked in the top 20 in 2018 in research expenditures among all public universities, according to the National Science Foundation, and is a leading Research 1 institution with $687 million in annual research expenditures. The university advances the frontiers of interdisciplinary scholarship and entrepreneurial partnerships as a member of the Association of American Universities, the 65 leading public and private research universities in the U.S. It benefits the state with an estimated economic impact of $4.1 billion annually. For more information: arizona.edu (Follow us: Facebook | Twitter | YouTube | LinkedIn | Instagram).

Original Story Link: